Sort
48,018 grants matching “immunotherapy”
New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors
$392,929Ann Richmond · Vanderbilt University · R01 · FY2020 · CA
Adoptive T cell Therapy of Melanoma Targeting NY-ESO-1
$392,915Cassian Yee · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
DNA BASED ADJUVANT IMMUNIZATION FOR HIV
$392,879University Of Pittsburgh At Pittsburgh · R01 · FY2002 · AI
Immune Regulation of Lung Squamous Metastasis
$392,837Chad V Pecot · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
Targeting ovarian cancer spheroid formation and metabolic adaptation by APJ inhibition
$392,820Sukyung Woo · State University Of New York At Buffalo · R01 · FY2023 · CA
Mechanisms for post-COVID pituitary damage
$392,800Takako Araki · University Of Minnesota · R01 · FY2022 · DK
In situ radioimmunotherapy to maximize the engagement of conventional type 1 dendritic cells against non-T cell-inflamed tumors
$392,779Fumito Ito · University Of Southern California · R01 · FY2025 · CA
Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors
$392,764Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Targeting tumor endothelium for cancer surveillance and immunotherapy
$392,740Sonia Sharma · La Jolla Institute For Immunology · R01 · FY2019 · CA
Immune Activating CAR-Modified Antigen Presenting Cells
$392,709Carl Deselm · Washington University · DP5 · FY2019 · OD
PRECLINICAL STUDIES ON NUCLEOLIN-DIRECTED IMMUNOTHERAPY OF BREAST CANCER
$392,677The Medical University Of South Carolina · · FY2012 · Department of Defense
Quantitatively modeling immune responses to cancer
$392,658Matthew Spitzer · University Of California, San Francisco · DP5 · FY2017 · OD
Leveraging Zika virus and the immune system to treat glioblastoma
$392,641Milan Girish Chheda · Washington University · R01 · FY2022 · NS
A Novel Broad-Spectrum Nanoimmunotherapeutic Approach for Combating Multidrug Resistant Bacteria
$392,634Shaoqin - Gong · University Of Wisconsin-Madison · R01 · FY2025 · AI
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
$392,632Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Structural dynamics of sphingosine-1-phosphate transporters as key therapeutic targets for immune system modulation and cancer
$392,627Reza Dastvan · Saint Louis University · R01 · FY2025 · GM
The role of extracellular matrix quality in the prediction of metastasis-induced skeletal fragility and response to immunotherapy
$392,617Stacyann R Bailey · University Of Massachusetts Amherst · R21 · FY2023 · CA
Advanced Rigidity-based Material for Enhanced Immunotherapy
$392,606Lance C Kam · Columbia University Health Sciences · R01 · FY2017 · AI
Whole-brain Spectroscopy Guided Personalized Mapping of Transducer Arrays for Glioblastoma Patients Receiving Tumor Treating Fields
$392,603Suyash Mohan · University Of Pennsylvania · R01 · FY2025 · CA
Core B: Animal Model and Immunotyping Core
$392,597Xiaoxia Li · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · CA
Core B: Animal Model and Immunotyping Core
$392,597Thaddeus S Stappenbeck · Cleveland Clinic Lerner Com-Cwru · P01 · FY2025 · CA
Anti-ceramide immunotherapy for diabetic retinopathy
$392,577Julia V Busik · Michigan State University · R01 · FY2020 · EY
Directing Function at the Natural Killer Cell Secretory Immunological Synapse
$392,571Jordan Scott Orange · Baylor College Of Medicine · R01 · FY2017 · AI
Identification of REV-ERB inverse agonists for cancer immunotherapy
$392,550Laura A Solt · Scripps Florida · R01 · FY2021 · CA
Project 1: Murine Modeling of Tumor-Mediated Immunosuppression
$392,528Edgar G. Engleman · Stanford University · U54 · FY2016 · CA